Enjoy complimentary customisation on priority with our Enterprise License!
The global biosensor market for non-clinical applications is anticipated to witness impressive growth and will post a staggering CAGR of more than 11% over the forecast period. Nanotechnology is an emerging technology that involves the study, creation, manipulation, and use of materials, devices, and systems with dimensions lesser than 100 nm. It also plays a crucial role in the development of biosensors. Nanomaterials not only help introduce several new signal transduction technologies in biosensors but also improve the sensitivity and performance of biosensors. The development of nanotech has resulted in an increase in the applications of nanomaterials in biosensors to a large extent. For example, nanomaterials-based biosensors can significantly increase the sensitivity and specificity of biomolecule detection, detect and manipulate atoms and molecules, and also show potential in applications such as biomolecular recognition, pathogenic diagnosis, and environment monitoring. Moreover, various kinds of nanomaterials, including carbon nanotubes, gold nanoparticles, and quantum dots are being increasingly used in biosensors due to their unique chemical, physical, mechanical, magnetic, and optical properties. The is anticipated to result in the manufacturing of better and more efficient biosensors, leading to their augmented adoption in the coming years.
The integration of biosensors with social networks is one of the significant trends driving this market’s growth during the predicted period. Health and other fitness-related statistics obtained with the help of biosensors become more relevant when the data can be compared with those of others. The Biogram app, which was launched in 2015, allows users to stamp their heart rate data on photos before sharing them on Instagram. Similar options are available for different types of fitness wearables that enable users to measure and compare their vital statistics to those of their peers and friends. Moreover, social network-based biosensors help patients keep a track of their daily drug dosage patterns. When a user gets in contact with a pill bottle, the biosensor patch on the bottle sends a signal to the user’s phone, which stores the data in the cloud. This data can be used by healthcare professionals to monitor the health of their patients, and is likely to revolutionize the overall healthcare market in the near future.
During 2015, the healthcare sector dominated the market and accounted for more than 44% of the market share in terms of revenue. The rising occurrence of lifestyle-related diseases and increasing health awareness among different types of consumers such as athletes, IT professionals, and old-age people will drive this segment’s growth over the next four years.
In terms of geography, North America dominated the market and is expected to reach more than USD 4 billion by 2020. North America has always been a pioneer in the adoption of new technologies and their implementation for a wide array of applications. Moreover, this region is home to a large number of notable OEMs for fitness trackers and wearables such as Apple, FitBit, Motorola, Jawbone, and Nike. These factors will contribute to the expansion of this market in North Americas until the end of 2020.
The global biosensors market for non-clinical applications is highly competitive owing to the presence of a large number of well-established vendors. The market is attracting several new companies due to the rapid adoption and increasing demand of biosensors for various applications. Players in the market are constantly looking for ways to enhance their market presence by focusing on the implementation of various new technology and M&A activities.
Key vendors in this market are -
Other prominent vendors in the market are 3M, Abbott Laboratories, Analog Devices, Bayer Healthcare Beckman Coulter, Becton, Dickinson and Company, Biacore International, Bio-Rad Laboratories, Biosensors International Group, Cambridge Life Sciences, DSM Biomedical, EMD Millipore, LifeScan, Nova Biomedical, Roche, and Siemens.
Technavio also offers customization on reports based on specific client requirement.
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Technology overview
PART 06: Market landscape
PART 07: Market segmentation by application
PART 08: Market segmentation by technology
PART 09: Geographical segmentation
PART 10: Summary of key figures
PART 11: Market drivers
PART 12: Impact of drivers
PART 13: Market challenges
PART 14: Impact of drivers and challenges
PART 15: Market trends
PART 16: Vendor landscape
PART 17: Appendix
PART 18: Explore Technavio
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.